Reckitt Benckiser Group plc (LON:RKT - Get Free Report) shares traded up 2.2% on Friday . The company traded as high as GBX 4,868 ($61.03) and last traded at GBX 4,847 ($60.76). 1,886,302 shares changed hands during trading, a decline of 41% from the average session volume of 3,203,260 shares. The stock had previously closed at GBX 4,741 ($59.43).
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. Berenberg Bank reduced their price objective on shares of Reckitt Benckiser Group from GBX 5,200 ($65.19) to GBX 5,177 ($64.90) and set a "hold" rating for the company in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered Reckitt Benckiser Group to a "neutral" rating in a report on Friday, August 30th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a GBX 4,400 ($55.16) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 29th.
Get Our Latest Report on RKT
Reckitt Benckiser Group Stock Up 2.2 %
The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 112.52. The stock has a market capitalization of £33.50 billion, a P/E ratio of 2,233.64, a P/E/G ratio of 1.10 and a beta of 0.09. The stock's 50-day moving average price is GBX 4,714.96 and its two-hundred day moving average price is GBX 4,495.23.
Insiders Place Their Bets
In other Reckitt Benckiser Group news, insider Fiona Dawson acquired 25 shares of Reckitt Benckiser Group stock in a transaction that occurred on Wednesday, October 23rd. The stock was acquired at an average cost of GBX 4,923 ($61.71) per share, for a total transaction of £1,230.75 ($1,542.87). Company insiders own 0.05% of the company's stock.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.